LeBas HB No. 174
(KEYWORD, SUMMARY, AND DIGEST as amended by Senate committee
amendments)
CONTROLLED SUBSTANCES: Provides with respect to the scheduling of controlled
dangerous substances.
DIGEST
HB 174 Reengrossed 2015 Regular Session LeBas
Present law provides for the designation of controlled dangerous substances into Schedules
I, II, III, IV, and V based upon the substances' potential for addiction and abuse.
Proposed law adds two substances to Schedule IV.
Present law provides that hydrocodone is a Schedule II drug, but is a Schedule III drug when
found in combination with other substances.
Proposed law repeals the Schedule III classification for hydrocodone combination products
to make La. law consistent with federal scheduling classifications.
Present law provides that a pharmacist cannot dispense more than a 10-day supply at a
dosage not to exceed the FDA's approved labeling for the medication if the prescriber for
such medication is not licensed by the state of Louisiana, and the medication is an opiod
derivative Schedule II or Schedule III controlled dangerous substance. Present law further
provides that the dispensing pharmacist must notify the prescriber of the supply dispensed
and the cancellation of the remainder of the prescription. Present law further provides that
within 60 days of the dispensing of a medication pursuant to present law, such medication
cannot be dispensed again for the individual by a prescriber not licensed by the state of
Louisiana.
Proposed law makes present law applicable to a pharmacist licensed by a state contiguous
to the state of Louisiana and deletes the 60-day limitation on dispensing the medication again
from present law.
Proposed law otherwise retains present law.
(Amends R.S. 40:978(E); adds R.S. 40:964(Schedule IV)(A)(3) and (B)(45.5); repeals R.S.
40:964(Schedule III)(D)(1)(c) and (d))
Effective upon signature of governor or lapse of time for gubernatorial action.
Summary of Amendments Adopted by House
The Committee Amendments Proposed by House Committee on Administration of
Criminal Justice to the original bill:
1. Add emergency effective date.
2. Provide penalties for violations involving Mitragynine and 7-Hydroxy-
mitragynine.
The House Floor Amendments to the engrossed bill:
1. Remove the proposed law addition of Mitragynine and 7-Hydroxy-mitragynine
into Schedule I and removes penalty provisions for violations involving those
substances.
Page 1 of 2
Prepared by Alden A. Clement, Jr. Summary of Amendments Adopted by Senate
Committee Amendments Proposed by Senate Committee on Judiciary C to the
reengrossed bill
1. Add provision making present law applicable to pharmacists licensed by states
contiguous to Louisiana.
2. Delete 60-day dispensing prohibition from present law.
Page 2 of 2
Prepared by Alden A. Clement, Jr.